Articles

Page 73 of 155

4th International Forum on Rheumatoid Arthritis: Great Times Near the Great Wall

Authors: David S Pisetsky

Citation: Arthritis Research & Therapy 2012 14:125

Content type: Editorial Published on: 27 September 2012
- View Full Text
- View PDF
Nonlymphoma hematological malignancies in systemic lupus erythematosus

Authors: M Lu, R Ramsey-Goldman, S Bernatsky, M Petri, S Manzi, MB Urowitz, D Gladman, PR Fortin, E Ginzler, E Yelin, S-C Bae, DJ Wallace, S Jacobsen, MA Dooley, CA Peschken, GS Alarcón…

Citation: Arthritis Research & Therapy 2012 14(Suppl 3):A64

Content type: Meeting abstract Published on: 27 September 2012

This article is part of a Supplement: Volume 14 Supplement 3
- View Full Text
- View PDF
Functional genetic polymorphisms in ILT3 are associated with decreased surface expression on dendritic cells and increased serum cytokines in lupus patients

Authors: MA Jensen, KC Patterson, AA Kumar, M Kumabe, BS Franek and TB Niewold

Citation: Arthritis Research & Therapy 2012 14(Suppl 3):A63

Content type: Meeting abstract Published on: 27 September 2012

This article is part of a Supplement: Volume 14 Supplement 3
- View Full Text
- View PDF
Prevalence of angina in patients with systemic lupus erythematosus

Authors: ML Ishimori, NJ Gal, A Rogatko, DS Berman, A Wilson, DJ Wallace, NB Merz and MH Weisman

Citation: Arthritis Research & Therapy 2012 14(Suppl 3):A62

Content type: Meeting abstract Published on: 27 September 2012

This article is part of a Supplement: Volume 14 Supplement 3
- View Full Text
- View PDF
Lupus cardiomyopathy: a reversible form of left ventricular dysfunction

Authors: ML Ishimori, M Agarwal, RK Ng, LD Nugent, DJ Wallace, RJ Siegel and MH Weisman

Citation: Arthritis Research & Therapy 2012 14(Suppl 3):A61

Content type: Meeting abstract Published on: 27 September 2012

This article is part of a Supplement: Volume 14 Supplement 3
- View Full Text
- View PDF
Hospitalizations in patients with systemic lupus erythematosus: updated analyses from 2006 to 2011

Authors: K Chan, A Dekis, AE Clarke, CA Pineau, E Vinet, E Nashi and S Bernatsky

Citation: Arthritis Research & Therapy 2012 14(Suppl 3):A59

Content type: Meeting abstract Published on: 27 September 2012

This article is part of a Supplement: Volume 14 Supplement 3
- View Full Text
- View PDF
Variation in renal biopsy and medication prescribing practices among pediatric Medicaid patients with lupus nephritis prior to end-stage renal disease in the US, 2000 to 2004

Authors: LT Hiraki, CH Feldman, J Liu, GS Alarcón, MA Fischer, WC Winkelmayer and KH Costenbader

Citation: Arthritis Research & Therapy 2012 14(Suppl 3):A58

Content type: Meeting abstract Published on: 27 September 2012

This article is part of a Supplement: Volume 14 Supplement 3
- View Full Text
- View PDF
Role of anti-Ro autoantibodies in systemic lupus erythematosus patients with recurrent myositis

Authors: S Umer, S Hayat, G Caldito and SM Berney

Citation: Arthritis Research & Therapy 2012 14(Suppl 3):A57

Content type: Meeting abstract Published on: 27 September 2012

This article is part of a Supplement: Volume 14 Supplement 3
- View Full Text
- View PDF
Development validation and reliability of the Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index-50

Authors: Z Touma, DD Gladman and MB Urowitz

Citation: Arthritis Research & Therapy 2012 14(Suppl 3):A55

Content type: Meeting abstract Published on: 27 September 2012

This article is part of a Supplement: Volume 14 Supplement 3
- View Full Text
- View PDF
Poor methodological reporting in lupus clinical trials found in Cochrane reviews

Authors: CH Goldsmith

Citation: Arthritis Research & Therapy 2012 14(Suppl 3):A54

Content type: Meeting abstract Published on: 27 September 2012

This article is part of a Supplement: Volume 14 Supplement 3
- View Full Text
- View PDF
Risk of pulmonary embolism and deep vein thrombosis in systemic lupus erythematosus: a population-based cohort study

Authors: JA Aviña-Zubieta, D Lacaille, EC Sayre, J Kopec, HK Choi and JM Esdaile

Citation: Arthritis Research & Therapy 2012 14(Suppl 3):A53

Content type: Meeting abstract Published on: 27 September 2012

This article is part of a Supplement: Volume 14 Supplement 3
- View Full Text
- View PDF
Hopkins Lupus Cohort: assessment of treatment effects

Authors: M Petri

Citation: Arthritis Research & Therapy 2012 14(Suppl 3):A52

Content type: Meeting abstract Published on: 27 September 2012

This article is part of a Supplement: Volume 14 Supplement 3
- View Full Text
- View PDF
Thinking toward improved treatments of systemic lupus erythematosus

Authors: BH Hahn, J Grossman, B Skaggs, E Lourenco and M Wong

Citation: Arthritis Research & Therapy 2012 14(Suppl 3):A51

Content type: Meeting abstract Published on: 27 September 2012

This article is part of a Supplement: Volume 14 Supplement 3
- View Full Text
- View PDF
High score on PREDICTS is associated with 10-fold increased odds for the progression of subclinical atherosclerosis in SLE

Authors: M McMahon, Lori Sahakian, J Grossman, B Skaggs, J Fitzgerald, C Charles-Schoeman, N Ragavendra, A Gorn, G Karpouzas, M Weisman, D Wallace and B Hahn

Citation: Arthritis Research & Therapy 2012 14(Suppl 3):A50

Content type: Meeting abstract Published on: 27 September 2012

This article is part of a Supplement: Volume 14 Supplement 3
- View Full Text
- View PDF
Sociodemographic characteristics of SLE patients in a large metropolitan area with a high Afro-Caribbean population

Authors: J Cabas-Vargas, NM Patel, J Cohen and EM Ginzler

Citation: Arthritis Research & Therapy 2012 14(Suppl 3):A49

Content type: Meeting abstract Published on: 27 September 2012

This article is part of a Supplement: Volume 14 Supplement 3
- View Full Text
- View PDF
Which lupus trial endpoints best reflect clinical judgment or biomarker improvement?

Authors: A Thanou, M Munroe, S Kamp, F Carthen, JA James and JT Merrill

Citation: Arthritis Research & Therapy 2012 14(Suppl 3):A47

Content type: Meeting abstract Published on: 27 September 2012

This article is part of a Supplement: Volume 14 Supplement 3
- View Full Text
- View PDF
Cytokine profiles of lupus patients with or without nephritis

Authors: BH Rovin, H Song, CL Hines and X Zhang

Citation: Arthritis Research & Therapy 2012 14(Suppl 3):A46

Content type: Meeting abstract Published on: 27 September 2012

This article is part of a Supplement: Volume 14 Supplement 3
- View Full Text
- View PDF
MicroRNAs in innate immune responses and autoimmune diseases

Authors: EKL Chan

Citation: Arthritis Research & Therapy 2012 14(Suppl 3):A42

Content type: Meeting abstract Published on: 27 September 2012

This article is part of a Supplement: Volume 14 Supplement 3
- View Full Text
- View PDF
Connecting the molecular dots from inaccessible antigen to organ injury in the pathogenesis of cardiac manifestations of neonatal lupus

Authors: JP Buyon

Citation: Arthritis Research & Therapy 2012 14(Suppl 3):A41

Content type: Meeting abstract Published on: 27 September 2012

This article is part of a Supplement: Volume 14 Supplement 3
- View Full Text
- View PDF
Complement deficiencies and susceptibility to systemic lupus erythematosus revisited

Authors: KB Elkon, DM Santer and A Wiedeman

Citation: Arthritis Research & Therapy 2012 14(Suppl 3):A40

Content type: Meeting abstract Published on: 27 September 2012

This article is part of a Supplement: Volume 14 Supplement 3
- View Full Text
- View PDF
PROMISSE: progress in understanding pregnancy complications in patients with SLE

Authors: JE Salmon

Citation: Arthritis Research & Therapy 2012 14(Suppl 3):A39

Content type: Meeting abstract Published on: 27 September 2012

This article is part of a Supplement: Volume 14 Supplement 3
- View Full Text
- View PDF
Evaluating the B-cell C3d:CR2 innate-adaptive immune interaction as a therapeutic target in lupus

Authors: VM Holers, JM Thurman, JP Hannan and L Kulik

Citation: Arthritis Research & Therapy 2012 14(Suppl 3):A38

Content type: Meeting abstract Published on: 27 September 2012

This article is part of a Supplement: Volume 14 Supplement 3
- View Full Text
- View PDF
Innate sensors for nucleic acids and lupus pathogenesis

Authors: AN Theofilopoulos, R Gonzalez-Quintial, Y-T Koh, R Baccala and DH Kono

Citation: Arthritis Research & Therapy 2012 14(Suppl 3):A37

Content type: Meeting abstract Published on: 27 September 2012

This article is part of a Supplement: Volume 14 Supplement 3
- View Full Text
- View PDF
Microparticles as autoantigens in human and murine lupus

Authors: A Ullal and DS Pisetsky

Citation: Arthritis Research & Therapy 2012 14(Suppl 3):A36

Content type: Meeting abstract Published on: 27 September 2012

This article is part of a Supplement: Volume 14 Supplement 3
- View Full Text
- View PDF
Interplay of neutrophils and type I interferons in the development of end-organ damage in SLE

Authors: MJ Kaplan

Citation: Arthritis Research & Therapy 2012 14(Suppl 3):A34

Content type: Meeting abstract Published on: 27 September 2012

This article is part of a Supplement: Volume 14 Supplement 3
- View Full Text
- View PDF
Role of MIF gene polymorphisms in systemic lupus erythematosus and prospects for therapeutic intervention

Authors: R Bucala

Citation: Arthritis Research & Therapy 2012 14(Suppl 3):A33

Content type: Meeting abstract Published on: 27 September 2012

This article is part of a Supplement: Volume 14 Supplement 3
- View Full Text
- View PDF
IRF5 expression profiling in SLE patients: new leads to a pathogenic signature?

Authors: BJ Barnes, RC Stone, P Du and D Feng

Citation: Arthritis Research & Therapy 2012 14(Suppl 3):A32

Content type: Meeting abstract Published on: 27 September 2012

This article is part of a Supplement: Volume 14 Supplement 3
- View Full Text
- View PDF
Spontaneous aggregation of the anti-viral MAVS protein in systemic lupus erythematosus: a possible cause of excessive type I interferon production

Authors: PL Cohen, B Hilliard and W-H Shao

Citation: Arthritis Research & Therapy 2012 14(Suppl 3):A31

Content type: Meeting abstract Published on: 27 September 2012

This article is part of a Supplement: Volume 14 Supplement 3
- View Full Text
- View PDF
Dysregulation of the serine/threonine phosphatase PP2A contributes to autoimmunity

Authors: JC Crispín

Citation: Arthritis Research & Therapy 2012 14(Suppl 3):A30

Content type: Meeting abstract Published on: 27 September 2012

This article is part of a Supplement: Volume 14 Supplement 3
- View Full Text
- View PDF
Genetic polymorphisms leading to altered T-cell and dendritic cell function cooperate to produce expansion of proinflammatory T-cell subsets in NZB c1 congenic mice

Authors: N Talaei, C Landolt-Marticorena, B Noamani, E Pau, N-H Chang and JE Wither

Citation: Arthritis Research & Therapy 2012 14(Suppl 3):A28

Content type: Meeting abstract Published on: 27 September 2012

This article is part of a Supplement: Volume 14 Supplement 3
- View Full Text
- View PDF
Regulatory natural autoantibodies suppress inflammation and SLE disease activity

Authors: GJ Silverman, J Vas and C Grönwall

Citation: Arthritis Research & Therapy 2012 14(Suppl 3):A27

Content type: Meeting abstract Published on: 27 September 2012

This article is part of a Supplement: Volume 14 Supplement 3
- View Full Text
- View PDF
SLE patients and autoantibody-positive healthy individuals display unique cytokine profiles: shared features of inflammation as well as select features of immunosuppression in autoantibody-positive healthy individuals

Authors: LL Ritterhouse, HT Maecker, CG Fathman, JT Merrill, JM Guthridge and JA James

Citation: Arthritis Research & Therapy 2012 14(Suppl 3):A26

Content type: Meeting abstract Published on: 27 September 2012

This article is part of a Supplement: Volume 14 Supplement 3
- View Full Text
- View PDF
B cells at the adaptive-innate immune system interface in SLE

Authors: JH Anolik, A Palanichamy, J Bauer, J Barnard, J Biear, R Dedrick, I Sanz, J Liesveld and E Baechler

Citation: Arthritis Research & Therapy 2012 14(Suppl 3):A24

Content type: Meeting abstract Published on: 27 September 2012

This article is part of a Supplement: Volume 14 Supplement 3
- View Full Text
- View PDF
Differing environmental risk factors for membranous versus proliferative lupus nephritis

Authors: MA Dooley, CG Parks and GS Cooper

Citation: Arthritis Research & Therapy 2012 14(Suppl 3):A23

Content type: Meeting abstract Published on: 27 September 2012

This article is part of a Supplement: Volume 14 Supplement 3
- View Full Text
- View PDF
Serum α-chlorofatty acid as a biomarker for baseline subclinical cardiovascular disease in systemic lupus erythematosus

Authors: MA Mahieu, C Guild, CJ Albert, G Kondos, J Carr, D Edmundowicz, DA Ford and R Ramsey-Goldman

Citation: Arthritis Research & Therapy 2012 14(Suppl 3):A22

Content type: Meeting abstract Published on: 27 September 2012

This article is part of a Supplement: Volume 14 Supplement 3
- View Full Text
- View PDF
Soluble E-selectin may predict progression of subclinical atherosclerosis, as measured by coronary artery calcium score and aorta calcium score, in women with systemic lupus erythematosus

Authors: A Lertratanakul, P Wu, A Dyer, W Pearce, G Kondos, D Edmundowicz, J Carr and R Ramsey-Goldman

Citation: Arthritis Research & Therapy 2012 14(Suppl 3):A21

Content type: Meeting abstract Published on: 27 September 2012

This article is part of a Supplement: Volume 14 Supplement 3
- View Full Text
- View PDF
Rising prevalence of systemic autoimmune rheumatic disease: increased awareness, increased disease or increased survival?

Authors: CA Peschken and CA Hitchon

Citation: Arthritis Research & Therapy 2012 14(Suppl 3):A20

Content type: Meeting abstract Published on: 27 September 2012

This article is part of a Supplement: Volume 14 Supplement 3
- View Full Text
- View PDF
Neuropsychiatric events in SLE: determination of attribution and assessment of outcome

Authors: JG Hanly

Citation: Arthritis Research & Therapy 2012 14(Suppl 3):A18

Content type: Meeting abstract Published on: 27 September 2012

This article is part of a Supplement: Volume 14 Supplement 3
- View Full Text
- View PDF
Usual source of care and geographic region are largest predictors of healthcare quality for incident lupus nephritis in US Medicaid recipients

Authors: J Yazdany, C Feldman, J Liu, MM Ward, MA Fischer and KH Costenbader

Citation: Arthritis Research & Therapy 2012 14(Suppl 3):A17

Content type: Meeting abstract Published on: 27 September 2012

This article is part of a Supplement: Volume 14 Supplement 3
- View Full Text
- View PDF
Lymphoma risk in systemic lupus: effects of treatment versus disease activity

Authors: AE Clarke, S Bernatsky, KH Costenbader, MB Urowitz, DD Gladman, PR Fortin, M Petri, S Manzi, DA Isenberg, A Rahman, D Wallace, C Gordon, C Peschken, MA Dooley, EM Ginzler, C Aranow…

Citation: Arthritis Research & Therapy 2012 14(Suppl 3):A16

Content type: Meeting abstract Published on: 27 September 2012

This article is part of a Supplement: Volume 14 Supplement 3
- View Full Text
- View PDF
Lung cancer in systemic lupus erythematosus

Authors: M Kale, R Ramsey-Goldman, S Bernatsky, MB Urowitz, D Gladman, PR Fortin, M Petri, E Yelin, S Manzi, S Edworthy, O Nived, S-C Bae, D Isenberg, A Rahman, JG Hanly, C Gordon…

Citation: Arthritis Research & Therapy 2012 14(Suppl 3):A15

Content type: Meeting abstract Published on: 27 September 2012

This article is part of a Supplement: Volume 14 Supplement 3
- View Full Text
- View PDF
Population-based study of preventable infections in hospitalized patients with systemic lupus erythematosus

Authors: CE Barber, C Barnabe, D Marshall and J Esdaile

Citation: Arthritis Research & Therapy 2012 14(Suppl 3):A14

Content type: Meeting abstract Published on: 27 September 2012

This article is part of a Supplement: Volume 14 Supplement 3
- View Full Text
- View PDF
Impact of systemic lupus erythematosus organ damage on unemployment or disability from a population-based cohort

Authors: SS Lim, M Agan and CM Drenkard

Citation: Arthritis Research & Therapy 2012 14(Suppl 3):A13

Content type: Meeting abstract Published on: 27 September 2012

This article is part of a Supplement: Volume 14 Supplement 3
- View Full Text
- View PDF
Area-level socioeconomic status and variation in medication use among Medicaid enrollees with incident systemic lupus erythematosus, 2000 to 2004

Authors: CH Feldman, LT Hiraki, J Lui, GS Alarcón, MA Fischer, J Yazdany and KH Costenbader

Citation: Arthritis Research & Therapy 2012 14(Suppl 3):A7

Content type: Meeting abstract Published on: 27 September 2012

This article is part of a Supplement: Volume 14 Supplement 3
- View Full Text
- View PDF
Differential DNA methylation associated with anti-dsDNA autoantibody production in systemic lupus erythematosus

Authors: SA Chung, J French, KE Taylor, E Elboudwarej, HL Quach, LF Barcellos and LA Criswell

Citation: Arthritis Research & Therapy 2012 14(Suppl 3):A6

Content type: Meeting abstract Published on: 27 September 2012

This article is part of a Supplement: Volume 14 Supplement 3
- View Full Text
- View PDF
MicroRNA-3148 modulates differential gene expression of the SLE-associated TLR7 variant

Authors: Y Deng, J Zhao, D Sakurai, KM Kaufman, JC Edberg, RP Kimberly, DL Kamen, GS Gilkeson, CO Jacob, RH Scofield, CD Langefeld, JA Kelly, ME Alarcón-Riquelme, JB Harley, TJ Vyse, BI Freedman…

Citation: Arthritis Research & Therapy 2012 14(Suppl 3):A5

Content type: Meeting abstract Published on: 27 September 2012

This article is part of a Supplement: Volume 14 Supplement 3
- View Full Text
- View PDF
Longitudinal analysis of mRNA transcripts and plasma proteins to define a biomarker associated with lupus disease activity

Authors: M Olferiev, W-T Huang, KA Kirou, E Gkrouzman, D Lundsgaard, KS Frederiksen, J Fleckner and MK Crow

Citation: Arthritis Research & Therapy 2012 14(Suppl 3):A3

Content type: Meeting abstract Published on: 27 September 2012

This article is part of a Supplement: Volume 14 Supplement 3
- View Full Text
- View PDF
Epigenetics and lupus

Authors: B Richardson

Citation: Arthritis Research & Therapy 2012 14(Suppl 3):A1

Content type: Meeting abstract Published on: 27 September 2012

This article is part of a Supplement: Volume 14 Supplement 3
- View Full Text
- View PDF
Expression of IL-20 in synovium and lesional skin of patients with psoriatic arthritis: differential response to alefacept treatment

Psoriatic arthritis (PsA) is an inflammatory joint disease associated with psoriasis. Alefacept (a lymphocyte function-associated antigen (LFA)-3 Ig fusion protein that binds to CD2 and functions as an antagon...

Authors: Maria C Lebre, Christina L Jonckheere, Maarten C Kraan, Arno WR van Kuijk, Jan D Bos, Menno de Rie, Danielle M Gerlag and Paul P Tak

Citation: Arthritis Research & Therapy 2012 14:R200

Content type: Research article Published on: 24 September 2012
- View Full Text
- View PDF
Ways forward to identify new ACPA targets in RA

Anti-citrullinated protein antibodies (ACPAs) of the IgG subtype have become a critical hallmark of HLA-associated rheumatoid arthritis (RA) and point to important contributions from the adaptive immune system...

Authors: A Jimmy Ytterberg and Vivianne Malmström

Citation: Arthritis Research & Therapy 2012 14:124

Content type: Editorial Published on: 24 September 2012
- View Full Text
- View PDF

How was your experience today?

Rating Please select one rating

Awful

Bad

Good

Great

Thank you for your feedback.

Tell us why (opens in a new tab)

Articles

Follow

Annual Journal Metrics

Arthritis Research & Therapy

Contact us